Pasechnikov V D, Chukov S Z, Kotelevets S M, Chabannaya T A
Department of Therapy, Medical Academy, Stavropol, Russian Federation.
Rocz Akad Med Bialymst. 2005;50:183-7.
To evaluate serum pepsinogen I (PG I) and gastrin-17 (G-17) levels in patients with Helicobacter pylori (H. pylori)-associated chronic atrophic gastritis, with reference to endoscopical Kimura-Takemoto's staging, chromoendoscopical and histological features.
267 dyspeptic H. pylori-infected patients were examined by chromoendoscopy with biopsy sampling according to the Sydney System and according to Kimura-Takemoto's scale. Simultaneous assessment of serum pepsinogen I (PG I) and gastrin-17 (G-17) levels by enzyme immunoassay was performed. The serologic and morphologic results were compared with correlation analysis.
There was strong reverse correlation between the stomach mucosal atrophy (antral part or corpus) and the proper serologic markers (respectively, G-17 or PG I) in H. pylori-associated chronic gastritis when gastric biopsies taken according to the Sydney System were assessed. The use of Kimura-Takemoto's scale has revealed the decrease of serum PG I levels only at 0-2 and 0-3 grades of the corpus mucosa atrophy. Probably, these results reflects the development of functional failure of the stomach corpus mucosa at late stages of atrophy when its compensatory capacity becomes insufficient. There were not any advantages in sampling biopsies for the detecting of intestinal metaplasia (IM) by the Sydney System, or by Kimura-Takemoto's scheme. The obvious concordance between histologically proven extent of IM and the number of IM foci detected by chromoendoscopy has been revealed.
The biopsy sampling for the diagnosis of precancerous changes of the stomach mucosa after non-invasive screening of atrophic gastritis (e.g., by means of EIA) should be based preferably on the visual signs acquired via chromoendoscopy than through routine endoscopy, independently of the scheme of examination of stomach mucosa, either according to the Sydney System, or to the Kimura-Takemoto's scale.
参照内镜下木村 - 竹本分期、色素内镜及组织学特征,评估幽门螺杆菌(H. pylori)相关性慢性萎缩性胃炎患者的血清胃蛋白酶原I(PG I)和胃泌素 - 17(G - 17)水平。
对267例有消化不良症状且感染H. pylori的患者,按照悉尼系统和木村 - 竹本标准进行色素内镜检查及活检取样。同时采用酶免疫分析法评估血清胃蛋白酶原I(PG I)和胃泌素 - 17(G - 17)水平。通过相关性分析比较血清学和形态学结果。
依据悉尼系统进行胃活检评估时,在H. pylori相关性慢性胃炎中,胃黏膜萎缩(胃窦部或胃体部)与相应的血清学标志物(分别为G - 17或PG I)之间存在强烈的负相关。使用木村 - 竹本标准仅显示在胃体黏膜萎缩的0 - 2级和0 - 3级时血清PG I水平降低。这些结果可能反映了萎缩后期胃体黏膜功能衰竭的发展,此时其代偿能力不足。在通过悉尼系统或木村 - 竹本方案进行活检取样以检测肠化生(IM)方面,并无任何优势。已揭示组织学证实的IM范围与色素内镜检测到的IM病灶数量之间存在明显的一致性。
在对萎缩性胃炎进行非侵入性筛查(如通过酶免疫分析法)后,针对胃黏膜癌前病变诊断的活检取样,无论采用悉尼系统还是木村 - 竹本标准的胃黏膜检查方案,最好基于色素内镜获得的视觉征象,而非常规内镜检查。